Database of patients with thyroid cancer at Institut Paoli-Calmettes
Official title: Institut Paoli Calmettes Thyroid Cancer Database
Run by Institut Paoli-Calmettes · NCT02869620 · Data updated 2026-11-12
This study is creating a database to collect information from thyroid cancer patients to help researchers understand the disease better and improve treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 95 Years |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Institut Paoli-Calmettes Academic / other |
| Locations | 1 site (Marseille, Bouches-du Rhône) |
| Status | Recruiting |
| Started | January 2010 |
| Main results expected | January 2030 |
| Study ends | December 2030 |
| Registry record updated | August 17, 2016 |
| Trial ID | NCT02869620 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with thyroid cancer.
✕Probably not a fit
Patients who do not have a diagnosis of thyroid cancer will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study involves the creation of a comprehensive database for patients diagnosed with thyroid cancer at the Institut Paoli-Calmettes. The database aims to collect and analyze clinical data to better understand the characteristics and outcomes of thyroid neoplasms. By gathering this information, researchers hope to identify patterns and improve future treatment strategies for thyroid cancer patients.
Why it matters
Potential benefit: If successful, this database could enhance understanding of thyroid cancer and lead to improved patient management and treatment options.
How similar studies have gone: While this approach is observational and may not have direct treatment implications, similar databases have been successful in enhancing knowledge and treatment of various cancers.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of thyroid cancer Exclusion Criteria: * Non applicable
Where it's running
-
Institut Paoli-Calmettes
Marseille, Bouches-du Rhône, France Recruiting
Study contacts
- Study coordinator: Dominique Genre, MD
- Email: drci.up@ipc.unicancer.fr
- Phone: 0033491223778
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
EMDR group program with optional individual EMDR for people with cancer
This project will try EMDR group therapy plus optional individual EMDR to reduce PTSD symptoms and psychological distress in people diagnosed with cancer.
-
Neoadjuvant treatment response in locally advanced thyroid cancer
This study will test whether neoadjuvant therapies can safely shrink locally advanced thyroid cancers and improve surgical outcomes for patients who then undergo thyroidectomy.
-
Hybrid endoscopic hemithyroidectomy plus targeted radiofrequency ablation for bilateral papillary thyroid cancer
It will test whether removing the larger tumor with a gas-less axillo-breast endoscopic hemithyroidectomy and treating a small opposite-side tumor with same-session radiofrequency ablation preserves thyroid function and controls cancer in adults with bilateral papillary thyroid carcinoma.
-
Dual-channel near-infrared imaging with AI to locate parathyroid glands
This project tests PTFinder, a device that uses near-infrared autofluorescence and AI to make removed thyroid or parathyroid tissue glow so doctors can quickly and accurately identify parathyroid glands in adults having thyroid or parathyroid surgery.
-
Web-based symptom support after radioactive iodine for differentiated thyroid cancer
This will test a four-week web program called RAI Support to help adults treated with radioactive iodine for differentiated thyroid cancer manage symptoms and improve overall quality of life compared with usual online information.
-
New endoscopic surgery technique for thyroid tumors
This study is testing a new way to perform thyroid surgery using a small dual-port technique to see if it is safer and more effective than the traditional open surgery for people with thyroid tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.